Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fortress Biotech, Inc. (FBIO) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fortress Biotech, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1429260.
Total stock buying since 2011: $14,202,850.
Total stock sales since 2011: $811,985.
Total stock option exercises since 2011: $113,999.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 858,859 | $1,688,544 | 10,000 | $18,900 | 0 | $0 |
| 2023 | 5,475,290 | $6,193,968 | 0 | $0 | 0 | $0 |
| 2022 | 200,000 | $137,500 | 0 | $0 | 0 | $0 |
| 2021 | 50,000 | $0 | 28,292 | $88,553 | 0 | $0 |
| 2020 | 119,167 | $1,245,006 | 28,450 | $124,611 | 0 | $0 |
| 2019 | 4,887 | $6,452 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 117,695 | $128,468 | 0 | $0 |
| 2017 | 40,000 | $1,000,000 | 56,593 | $202,308 | 0 | $0 |
| 2016 | 1,344 | $2,954 | 48,912 | $124,575 | 0 | $0 |
| 2015 | 1,371 | $2,825 | 0 | $0 | 0 | $0 |
| 2014 | 1,185,974 | $1,907,262 | 66,667 | $124,570 | 66,667 | $113,999 |
| 2013 | 67,134 | $422,072 | 0 | $0 | 0 | $0 |
| 2012 | 315,122 | $1,582,267 | 0 | $0 | 0 | $0 |
| 2011 | 2,000 | $14,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 763,359 | $1,404,580 | 0 | $0 | 0 | $0 |
| 2024-07 | 15,500 | $114,905 | 0 | $0 | 0 | $0 |
| 2024-06 | 20,000 | $32,719 | 0 | $0 | 0 | $0 |
| 2024-05 | 10,000 | $17,590 | 10,000 | $18,900 | 0 | $0 |
| 2024-01 | 50,000 | $118,750 | 0 | $0 | 0 | $0 |
| 2023-11 | 1,714,573 | $2,914,773 | 0 | $0 | 0 | $0 |
| 2023-09 | 100,000 | $28,299 | 0 | $0 | 0 | $0 |
| 2023-08 | 20,000 | $210,900 | 0 | $0 | 0 | $0 |
| 2023-02 | 3,640,717 | $3,039,996 | 0 | $0 | 0 | $0 |
| 2022-12 | 100,000 | $68,000 | 0 | $0 | 0 | $0 |
| 2022-10 | 100,000 | $69,500 | 0 | $0 | 0 | $0 |
| 2021-09 | 0 | $0 | 28,292 | $88,553 | 0 | $0 |
| 2021-01 | 50,000 | $0 | 0 | $0 | 0 | $0 |
| 2020-09 | 0 | $0 | 28,450 | $124,611 | 0 | $0 |
| 2020-08 | 69,167 | $1,245,006 | 0 | $0 | 0 | $0 |
| 2020-01 | 50,000 | $0 | 0 | $0 | 0 | $0 |
| 2019-12 | 1,123 | $2,313 | 0 | $0 | 0 | $0 |
| 2019-06 | 3,764 | $4,139 | 0 | $0 | 0 | $0 |
| 2018-12 | 0 | $0 | 97,325 | $102,191 | 0 | $0 |
| 2018-11 | 0 | $0 | 20,370 | $26,277 | 0 | $0 |
| 2017-12 | 0 | $0 | 56,593 | $202,308 | 0 | $0 |
| 2017-11 | 40,000 | $1,000,000 | 0 | $0 | 0 | $0 |
| 2016-12 | 731 | $1,483 | 0 | $0 | 0 | $0 |
| 2016-09 | 0 | $0 | 48,912 | $124,575 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-23 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 763,359 | 1.84 | 1,404,580 |
| 2024-07-11 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 5,000 | 7.48 | 37,420 |
| 2024-07-10 | Jin David (Chief Financial Officer) | Buy | 500 | 7.50 | 3,750 |
| 2024-07-09 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 5,000 | 7.39 | 36,970 |
| 2024-07-08 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 5,000 | 7.35 | 36,765 |
| 2024-06-28 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 20,000 | 1.64 | 32,719 |
| 2024-05-20 | Klein Dov | Sale | 10,000 | 1.89 | 18,900 |
| 2024-05-16 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 10,000 | 1.76 | 17,590 |
| 2024-01-05 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 50,000 | 2.38 | 118,750 |
| 2023-11-14 | Weiss Michael S (See Remarks) | Buy | 147,058 | 1.70 | 249,998 |
| 2023-11-14 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 1,567,515 | 1.70 | 2,664,775 |
| 2023-09-26 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 100,000 | .28 | 28,299 |
| 2023-08-18 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 10,000 | 9.34 | 93,400 |
| 2023-08-17 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 10,000 | 11.75 | 117,500 |
| 2023-02-10 | Jin David (Chief Financial Officer) | Buy | 35,928 | .83 | 29,999 |
| 2023-02-10 | Rowinsky Eric K | Buy | 11,976 | .83 | 9,999 |
| 2023-02-10 | Weiss Michael S (See Remarks) | Buy | 1,197,604 | .83 | 999,999 |
| 2023-02-10 | Rosenwald Lindsay A Md (President, CEO & Chairman) | Buy | 2,395,209 | .83 | 1,999,999 |
| 2022-12-01 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 100,000 | .68 | 68,000 |
| 2022-10-21 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 100,000 | .69 | 69,500 |
| 2021-09-21 | Hunter Robyn (Chief Financial Officer) | Sale | 28,292 | 3.13 | 88,553 |
| 2021-01-01 | Lorenz Kevin | Buy | 50,000 | .00 | 0 |
| 2020-09-22 | Hunter Robyn (Chief Financial Officer) | Sale | 28,450 | 4.38 | 124,611 |
| 2020-08-26 | Hoenlein Malcolm | Buy | 16,667 | 18.00 | 300,006 |
| 2020-08-26 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 52,500 | 18.00 | 945,000 |
| 2020-01-01 | Lorenz Kevin | Buy | 50,000 | .00 | 0 |
| 2019-12-01 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 1,123 | 2.06 | 2,313 |
| 2019-06-03 | Hunter Robyn (Chief Financial Officer) | Buy | 2,297 | 1.10 | 2,526 |
| 2019-06-03 | Rosenwald Lindsay A Md (PRESIDENT, CEO & CHAIRMAN) | Buy | 1,467 | 1.10 | 1,613 |
| 2018-12-11 | Avgerinos George (SVP, BIOLOGICS OPERATIONS) | Sale | 97,325 | 1.05 | 102,191 |
| 2018-11-23 | Hunter Robyn (Chief Financial Officer) | Sale | 20,370 | 1.29 | 26,277 |
| 2017-12-14 | Avgerinos George (SVP, BIOLOGICS OPERATIONS) | Sale | 12,000 | 3.55 | 42,600 |
| 2017-12-13 | Avgerinos George (SVP, BIOLOGICS OPERATIONS) | Sale | 19,000 | 3.57 | 67,830 |
| 2017-12-12 | Avgerinos George (SVP, BIOLOGICS OPERATIONS) | Sale | 25,593 | 3.59 | 91,878 |
| 2017-11-06 | Rosenwald Lindsay A Md (PRESIDENT, CEO) | Buy | 40,000 | 25.00 | 1,000,000 |
| 2016-12-01 | Rosenwald Lindsay A Md (President and CEO) | Buy | 731 | 2.03 | 1,483 |
| 2016-09-16 | Avgerinos George (SVP, Biologics Operations) | Sale | 33,912 | 2.55 | 86,475 |
| 2016-09-15 | Avgerinos George (SVP, Biologics Operations) | Sale | 15,000 | 2.54 | 38,100 |
| 2016-06-01 | Rosenwald Lindsay A Md (President and CEO) | Buy | 613 | 2.40 | 1,471 |
| 2015-12-01 | Rosenwald Lindsay A Md (President and CEO) | Buy | 586 | 2.41 | 1,412 |
| 2015-06-01 | Rosenwald Lindsay A Md (President and CEO) | Buy | 785 | 1.80 | 1,413 |
| 2014-12-01 | Lu Lucy (Chief Financial Officer) | Buy | 5,000 | 1.45 | 7,250 |
| 2014-12-01 | Rosenwald Lindsay A Md (President and CEO) | Buy | 974 | 1.45 | 1,412 |
| 2014-11-06 | Hoenlein Malcolm (Director) | Buy | 25,000 | 1.61 | 40,250 |
| 2014-11-06 | Weiss Michael S (Exec. VC - Strategic Dev.) | Buy | 1,000,000 | 1.61 | 1,610,000 |
| 2014-11-06 | Rosenwald Lindsay A Md (President and CEO) | Buy | 150,000 | 1.61 | 241,500 |
| 2014-06-02 | Lu Lucy (Chief Financial Officer) | Buy | 5,000 | 1.37 | 6,850 |
| 2014-04-22 | Horgan Kevin (Other) | Sale | 47,566 | 1.89 | 89,994 |
| 2014-04-22 | Horgan Kevin (Other) | Option Ex | 47,566 | 1.71 | 81,337 |
| 2014-04-21 | Horgan Kevin (Other) | Sale | 19,000 | 1.81 | 34,390 |
| 2014-04-21 | Horgan Kevin (Other) | Option Ex | 19,000 | 1.71 | 32,490 |
| 2014-04-17 | Horgan Kevin (Other) | Sale | 101 | 1.85 | 186 |
| 2014-04-17 | Horgan Kevin (Other) | Option Ex | 101 | 1.71 | 172 |
| 2013-12-04 | Lu Lucy (Chief Financial Officer) | Buy | 1,107 | 1.39 | 1,538 |
| 2013-08-21 | Lu Lucy (Chief Financial Officer) | Buy | 5,000 | 7.38 | 36,900 |
| 2013-08-21 | Lobell J Jay (Director) | Buy | 5,000 | 7.37 | 36,850 |
| 2013-07-17 | Lu Lucy (Chief Financial Officer) | Buy | 4,545 | 7.90 | 35,905 |
| 2013-06-20 | Weisman Harlan F (Chairman and CEO) | Buy | 10,000 | 7.59 | 75,900 |
| 2013-06-20 | Lobell J Jay (Director) | Buy | 10,000 | 7.62 | 76,230 |
| 2013-05-31 | Lu Lucy (Chief Financial Officer) | Buy | 4,979 | 3.88 | 19,318 |
| 2013-05-31 | Beerman Noah D (Executive VP and COO) | Buy | 5,000 | 3.88 | 19,400 |
| 2013-05-31 | Ritter Dale (SVP & Chief Accounting Officer) | Buy | 1,503 | 3.88 | 5,831 |
| 2013-01-14 | Weisman Harlan F (Chairman and CEO) | Buy | 20,000 | 5.71 | 114,200 |
| 2012-11-30 | Sandage Bobby W Phd (President and CEO) | Buy | 3,811 | 4.02 | 15,320 |
| 2012-11-30 | Cooper Glenn L Md (See Remarks) | Buy | 3,811 | 4.02 | 15,320 |
| 2012-06-22 | Hehenberger Karin M. (See Remarks) | Buy | 20,000 | 5.00 | 100,000 |
| 2012-06-22 | Lu Lucy (Chief Financial Officer) | Buy | 10,000 | 5.00 | 50,000 |
| 2012-06-22 | Beerman Noah D (EVP & COO) | Buy | 5,000 | 5.00 | 25,000 |
| 2012-06-22 | Ritter Dale (SVP & Chief Accounting Officer) | Buy | 5,000 | 5.00 | 25,000 |
| 2012-06-22 | Lobell J Jay (Director) | Buy | 25,000 | 5.00 | 125,000 |
| 2012-06-22 | Sandage Bobby W Phd (President and CEO) | Buy | 10,000 | 5.00 | 50,000 |
| 2012-06-22 | Cooper Glenn L Md (See Remarks) | Buy | 10,000 | 5.30 | 52,970 |
| 2012-06-22 | Rosenwald Lindsay A Md (Director) | Buy | 200,000 | 5.00 | 1,000,000 |
| 2012-01-23 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 6.95 | 13,900 |
| 2012-01-20 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.66 | 11,320 |
| 2012-01-19 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.67 | 11,340 |
| 2012-01-18 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.66 | 11,320 |
| 2012-01-17 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.40 | 10,800 |
| 2012-01-13 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.40 | 10,800 |
| 2012-01-12 | Beerman Noah D (See Remarks) | Buy | 5,000 | 4.99 | 24,960 |
| 2012-01-12 | Sandage Bobby W Phd (President and CEO) | Buy | 1,000 | 5.20 | 5,195 |
| 2012-01-12 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.20 | 10,400 |
| 2012-01-11 | Sandage Bobby W Phd (President and CEO) | Buy | 500 | 5.28 | 2,642 |
| 2012-01-11 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 5.49 | 10,980 |
| 2011-12-08 | Rosenwald Lindsay A Md (Director) | Buy | 2,000 | 7.00 | 14,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fortress Biotech, Inc. (symbol FBIO, CIK number 1429260) see the Securities and Exchange Commission (SEC) website.